Form 8-K - Current report:
SEC Accession No. 0001493152-22-014716
Filing Date
2022-05-23
Accepted
2022-05-23 11:16:04
Documents
13
Period of Report
2022-05-23
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42536
  Complete submission text file 0001493152-22-014716.txt   259737

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bblg-20220523.xsd EX-101.SCH 3742
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bblg-20220523_def.xml EX-101.DEF 26661
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bblg-20220523_lab.xml EX-101.LAB 36757
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bblg-20220523_pre.xml EX-101.PRE 25285
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5548
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40899 | Film No.: 22950175
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies